ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
OxyChem has picked membrane electrolysis technology from Thyssenkrupp Nucera to replace the diaphragm technology at its largest chlor-alkali facility, in LaPorte, Texas. The project is expected to take 3 years. The US Environmental Protection Agency has proposed banning US imports of the chrysotile asbestos used to make the diaphragms. Olin, another large chlor-alkali maker, said in April that it plans to phase out asbestos diaphragms. Westlake, the other US chlor-alkali maker that uses the diaphragms, says it is in the midst of a multiyear conversion of its one asbestos-based plant in the US.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X